GFAP and dementia: Compared to participants who were Aβ−, those who were Aβ+ were older; had a lower body mass index; had greater rates of dementia and carrying APOE ε4; had lower MMSE and CDR scores; and had greater p‐tau217, p‐tau181, and GFAP levels.